182 related articles for article (PubMed ID: 11827520)
21. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site.
Fleury S; Lamarre D; Meloche S; Ryu SE; Cantin C; Hendrickson WA; Sekaly RP
Cell; 1991 Sep; 66(5):1037-49. PubMed ID: 1889086
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of the gp120-binding area of murine and human CD4 molecules.
Siddiqi MA; Tachibana M; Ohta S; Ikegami Y; Tahara-Hanaoka S; Huang YY; Shinohara N
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):7-12. PubMed ID: 8989204
[TBL] [Abstract][Full Text] [Related]
23. The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.
Crublet E; Andrieu JP; Vivès RR; Lortat-Jacob H
J Biol Chem; 2008 May; 283(22):15193-200. PubMed ID: 18378683
[TBL] [Abstract][Full Text] [Related]
24. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
[TBL] [Abstract][Full Text] [Related]
25. Structure and interactions of CD4.
Harrison SC; Wang J; Yan Y; Garrett T; Liu J; Moebius U; Reinherz E
Cold Spring Harb Symp Quant Biol; 1992; 57():541-8. PubMed ID: 1339691
[No Abstract] [Full Text] [Related]
26. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding.
Li Y; Luo L; Rasool N; Kang CY
J Virol; 1993 Jan; 67(1):584-8. PubMed ID: 8416385
[TBL] [Abstract][Full Text] [Related]
27. Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding.
Wu H; Myszka DG; Tendian SW; Brouillette CG; Sweet RW; Chaiken IM; Hendrickson WA
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15030-5. PubMed ID: 8986758
[TBL] [Abstract][Full Text] [Related]
28. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120.
Sakihama T; Smolyar A; Reinherz EL
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6444-8. PubMed ID: 7604010
[TBL] [Abstract][Full Text] [Related]
29. Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent.
Chamow SM; Kogan TP; Peers DH; Hastings RC; Byrn RA; Ashkenazi A
J Biol Chem; 1992 Aug; 267(22):15916-22. PubMed ID: 1639820
[TBL] [Abstract][Full Text] [Related]
30. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
31. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
32. CD4-affinity purification of recombinant and native HIV gp120 and comparison of the affinity constants for the receptor.
Moritz D; Dirckx L; Mous J; Schneider J
FEBS Lett; 1990 Nov; 275(1-2):146-50. PubMed ID: 2261984
[TBL] [Abstract][Full Text] [Related]
33. Energetics of the HIV gp120-CD4 binding reaction.
Myszka DG; Sweet RW; Hensley P; Brigham-Burke M; Kwong PD; Hendrickson WA; Wyatt R; Sodroski J; Doyle ML
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9026-31. PubMed ID: 10922058
[TBL] [Abstract][Full Text] [Related]
34. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.
Thali M; Olshevsky U; Furman C; Gabuzda D; Li J; Sodroski J
J Virol; 1991 Sep; 65(9):5007-12. PubMed ID: 1870209
[TBL] [Abstract][Full Text] [Related]
35. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
36. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.
Fu YK; Hart TK; Jonak ZL; Bugelski PJ
J Virol; 1993 Jul; 67(7):3818-25. PubMed ID: 8510207
[TBL] [Abstract][Full Text] [Related]
37. CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.
Pandey D; Podder A; Pandit M; Latha N
J Biomol Struct Dyn; 2017 Sep; 35(12):2631-2644. PubMed ID: 27545652
[TBL] [Abstract][Full Text] [Related]
38. Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection.
Peakman M; Senaldi G; Foote N; McManus TJ; Vergani D
J Infect Dis; 1992 May; 165(5):799-804. PubMed ID: 1349032
[TBL] [Abstract][Full Text] [Related]
39. Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments.
Cheng K; El-Boubbou K; Landry CC
ACS Appl Mater Interfaces; 2012 Jan; 4(1):235-43. PubMed ID: 22117536
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus.
Xie H; Ng D; Savinov SN; Dey B; Kwong PD; Wyatt R; Smith AB; Hendrickson WA
J Med Chem; 2007 Oct; 50(20):4898-908. PubMed ID: 17803292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
